Neuronetics STIM Stock
Neuronetics Price Chart
Neuronetics STIM Financial and Trading Overview
| Neuronetics stock price | 3.1 USD |
| Previous Close | 2.38 USD |
| Open | 2.41 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1000 |
| Day's Range | 2.34 - 2.42 USD |
| 52 Week Range | 2.01 - 6.95 USD |
| Volume | 66.93K USD |
| Avg. Volume | 168.24K USD |
| Market Cap | 66.69M USD |
| Beta (5Y Monthly) | 1.927631 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.67 USD |
STIM Valuation Measures
| Enterprise Value | 52.68M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.2075472 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0019025 |
| Price/Book (mrq) | 1.3780918 |
| Enterprise Value/Revenue | 0.791 |
| Enterprise Value/EBITDA | -1.624 |
Trading Information
Neuronetics Stock Price History
| Beta (5Y Monthly) | 1.927631 |
| 52-Week Change | -30.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.95 USD |
| 52 Week Low | 2.01 USD |
| 50-Day Moving Average | 2.47 USD |
| 200-Day Moving Average | 4.04 USD |
STIM Share Statistics
| Avg. Volume (3 month) | 168.24K USD |
| Avg. Daily Volume (10-Days) | 113.87K USD |
| Shares Outstanding | 28.5M |
| Float | 22.6M |
| Short Ratio | 1.93 |
| % Held by Insiders | 5.30% |
| % Held by Institutions | 68.07% |
| Shares Short | 339.16K |
| Short % of Float | 1.39% |
| Short % of Shares Outstanding | 1.19% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -55.34% |
| Operating Margin (ttm) | -51.50% |
| Gross Margin | 75.75% |
| EBITDA Margin | -48.73% |
Management Effectiveness
| Return on Assets (ttm) | -18.34% |
| Return on Equity (ttm) | -58.97% |
Income Statement
| Revenue (ttm) | 66.57M USD |
| Revenue Per Share (ttm) | 2.44 USD |
| Quarterly Revenue Growth (yoy) | 9.59% |
| Gross Profit (ttm) | 49.72M USD |
| EBITDA | -32438000 USD |
| Net Income Avi to Common (ttm) | -36841000 USD |
| Diluted EPS (ttm) | -1.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 55.44M USD |
| Total Cash Per Share (mrq) | 1.95 USD |
| Total Debt (mrq) | 40.29M USD |
| Total Debt/Equity (mrq) | 83.33 USD |
| Current Ratio (mrq) | 5.361 |
| Book Value Per Share (mrq) | 1.698 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33770000 USD |
| Levered Free Cash Flow (ttm) | -18080624 USD |
Profile of Neuronetics
| Country | United States |
| State | PA |
| City | Malvern |
| Address | 3222 Phoenixville Pike |
| ZIP | 19355 |
| Phone | 610 640 4202 |
| Website | https://neurostar.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 200 |
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Q&A For Neuronetics Stock
What is a current STIM stock price?
Neuronetics STIM stock price today per share is 3.1 USD.
How to purchase Neuronetics stock?
You can buy STIM shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neuronetics?
The stock symbol or ticker of Neuronetics is STIM.
Which industry does the Neuronetics company belong to?
The Neuronetics industry is Diagnostics & Research.
How many shares does Neuronetics have in circulation?
The max supply of Neuronetics shares is 55.65M.
What is Neuronetics Price to Earnings Ratio (PE Ratio)?
Neuronetics PE Ratio is now.
What was Neuronetics earnings per share over the trailing 12 months (TTM)?
Neuronetics EPS is -1.22 USD over the trailing 12 months.
Which sector does the Neuronetics company belong to?
The Neuronetics sector is Healthcare.
Neuronetics STIM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 19627.44 USD — |
-0.28
|
7.47B USD — | 19575.21 USD — | 19969.17 USD — | — - | 7.47B USD — |
| NASDAQ Global Market Composite NQGM | 2352.03 USD — |
-0.99
|
— — | 2341.77 USD — | 2397.99 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 1022.81 USD — |
-0.5
|
— — | 1021.97 USD — | 1039.72 USD — | — - | — — |
- {{ link.label }} {{link}}